Showing 1 - 3 results of 3 for search 'Werner Engl', query time: 0.04s Refine Results
  1. 1
    Long-term adverse events, efficacy, and tolerability of recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin in patients aged < 18 years with primary immunodeficiency diseases
    Get full text
    Article
  2. 2
    Local adverse reaction rates decreased over time during treatment with recombinant human hyaluronidase-facilitated subcutaneous infusion of immunoglobulin G (fSCIG) in patients with primary immunodeficiency diseases in the fSCIG phase 3 studies
    Get full text
    Article
  3. 3
    Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search